• Explore /
  • Poster
  • / A phase II study to evaluate the safety and efficacy of OQL011 on VEGFR inhibitor-associated hand-foot-skin reaction in cancer patients.

A phase II study to evaluate the safety and efficacy of OQL011 on VEGFR inhibitor-associated hand-foot-skin reaction in cancer patients.

Abstract Video & Slides Poster

Authors

Mario Lacouture

Mario E. Lacouture

Memorial Sloan Kettering Cancer Center, New York, NY

Mario E. Lacouture , Milan J. Anadkat , Omkar Subhash Marathe , Nicholas J. Vogelzang , Elaine Tat Lam , Benjamin Kaffenberger , Jennifer N. Choi , Mark L. Webb , Robert Claude Tyler , Juegang Ju , Hong Tang , Jie Luo , Anisha Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

NCT04088318

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS12132)

DOI

10.1200/JCO.2021.39.15_suppl.TPS12132

Abstract #

TPS12132

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Mario E. Lacouture

First Author: Anisha B Patel

First Author: Lorenza Rimassa

First Author: Axel Le Cesne